Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

ProEncia Biotechnology

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Medium growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Saint Paul, Minnesota, United States Founded 2022 1-10 employees For Profit

ProEncia Biotechnology develops therapeutics for periodontal disease.

ProEncia Biotechnology on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Funding Rounds
1
Last Funding
Acquisitions
0
Monthly Visits
Contacts
1

About ProEncia Biotechnology

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
4
IT spend
$55.75K

Company Info

Founded
2022
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
News articles
6
HQ
Saint Paul, Minnesota, United States
Region
Greater Minneapolis-Saint Paul Area, Great Lakes, Midwestern US

Signals & Scores

Heat score
Medium
Growth score
Medium
Trend (7d)
-0.8
Trend (30d)
-3.1
Trend (90d)
6.7

ProEncia Biotechnology Funding Rounds

1 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesOrg Hq Country
1–1 of 1Show
Page 1 / 1
1
professional contacts at ProEncia Biotechnology
Contact execs at ProEncia Biotechnology

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to ProEncia Biotechnology

Loading news…

FAQs about ProEncia Biotechnology

People who checked this page also checked these

Browse the full Acquirezy directory.